Literature DB >> 20919861

Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.

Jayaram Vijayakrishnan1, Amy L Sherborne, Ruchchadol Sawangpanich, Suradej Hongeng, Richard S Houlston, Samart Pakakasama.   

Abstract

Recent genome-wide association (GWA) studies of childhood acute lymphoblastic leukemia (ALL) have identified 7p12.2, 9p21.3, 10q21.2, and 14q11.2 SNPs that confer modest risks of ALL. These studies have been conducted in European populations, and it is unclear whether these observations generalize to other populations with a lower incidence of ALL. To explore the impact of these variants on ALL risk in the Thai population, we genotyped 190 cases of ALL and 182 controls for SNPs rs4132601 (7p12.2), rs3731217 (9p21.3), rs7089424 and rs10821938 (10q21.2), and rs2239633 (14q11.2). Consistent with findings in European populations, rs4132601 genotype was significantly associated with risk of ALL (odds ratio [OR] = 1.57, 95% confidence interval [CI]: 1.01-2.44; p = 0.04), and rs10821938 genotype was significantly associated with B-cell precursor ALL (OR = 0.73, 95% CI: 0.55-0.97; p = 0.03). There were, however, differences in allele frequencies in SNPs observed between Thai and Caucasian populations (e.g. IKZF1, rs4132601; risk allele frequency [RAF] ratio of 0.36 for Thai/Caucasian). These differences, combined with differences in linkage disequilibrium structure between populations or differences in effect size between populations, may contribute to racial differences in ALL incidence.

Entities:  

Mesh:

Year:  2010        PMID: 20919861     DOI: 10.3109/10428194.2010.511356

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  26 in total

1.  Meta-analysis of the association between CCAAT/enhancer binding protein-ε polymorphism and the risk of childhood acute lymphoblastic leukemia.

Authors:  Yangqiong Pan; Hao Chen; Hong Liang; Xiaowen Wang; Lingling Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility.

Authors:  Ángela Gutiérrez-Camino; Elixabet López-López; Idoia Martín-Guerrero; José Sánchez-Toledo; Nagore García de Andoin; Ana Carboné Bañeres; Purificación García-Miguel; Aurora Navajas; África García-Orad
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-08       Impact factor: 4.553

Review 3.  Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.

Authors:  Lindsay A Williams; Jun J Yang; Betsy A Hirsch; Erin L Marcotte; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-15       Impact factor: 4.254

Review 4.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

5.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Authors:  Heng Xu; Cheng Cheng; Meenakshi Devidas; Deqing Pei; Yiping Fan; Wenjian Yang; Geoff Neale; Paul Scheet; Esteban G Burchard; Dara G Torgerson; Celeste Eng; Michael Dean; Frederico Antillon; Naomi J Winick; Paul L Martin; Cheryl L Willman; Bruce M Camitta; Gregory H Reaman; William L Carroll; Mignon Loh; William E Evans; Ching-Hon Pui; Stephen P Hunger; Mary V Relling; Jun J Yang
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

Review 6.  Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Amy L Sherborne; Kari Hemminki; Rajiv Kumar; Claus R Bartram; Martin Stanulla; Martin Schrappe; Eleni Petridou; Agnes F Semsei; Csaba Szalai; Daniel Sinnett; Maja Krajinovic; Jasmine Healy; Marina Lanciotti; Carlo Dufour; Stefania Indaco; Eman A El-Ghouroury; Ruchchadol Sawangpanich; Suradej Hongeng; Samart Pakakasama; Anna Gonzalez-Neira; Evelia L Ugarte; Valeria P Leal; Juan P M Espinoza; Azza M Kamel; Gamal T A Ebid; Eman R Radwan; Serap Yalin; Erdinc Yalin; Mehmet Berkoz; Jill Simpson; Eve Roman; Tracy Lightfoot; Fay J Hosking; Jayaram Vijayakrishnan; Mel Greaves; Richard S Houlston
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

7.  Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.

Authors:  Ling-I Hsu; Anand P Chokkalingam; Farren B S Briggs; Kyle Walsh; Vonda Crouse; Cecilia Fu; Catherine Metayer; Joseph L Wiemels; Lisa F Barcellos; Patricia A Buffler
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

Review 8.  Genetic susceptibility in childhood acute lymphoblastic leukemia.

Authors:  Angela Gutierrez-Camino; Idoia Martin-Guerrero; Africa García-Orad
Journal:  Med Oncol       Date:  2017-09-13       Impact factor: 3.064

9.  Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children.

Authors:  K M Walsh; A P Chokkalingam; L-I Hsu; C Metayer; A J de Smith; D I Jacobs; G V Dahl; M L Loh; I V Smirnov; K Bartley; X Ma; J K Wiencke; L F Barcellos; J L Wiemels; P A Buffler
Journal:  Leukemia       Date:  2013-04-25       Impact factor: 11.528

10.  ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Amy M Linabery; Crystal N Blommer; Logan G Spector; Stella M Davies; Leslie L Robison; Julie A Ross
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.